Table 1.
Demographics of patients with severe COVID-19 who did and did not require continuous renal replacement therapy (CRRRT) during hospitalization (p-values comparing patients who did and did not require CRRT.
| All n = 116 |
AKI Stage 1 n = 24 (20.9%) |
AKI Stage 2 n = 15 (12.9%) |
AKI Stage 3 n = 37 (31.9%) |
CRRT n = 45 (38.8%) |
No CRRT n = 71 (61.2%) |
P value | |
|---|---|---|---|---|---|---|---|
| Female Sex (%) | 41 (35.3%) | 25 (32.9%) | 19 (36.5%) | 12 (32.4%) | 14 (31.1%) | 27 (38%) | ns |
| Age (years) | 61.5 +/− 12.1 | 62 +/− 12.1 | 68.4 +/− 10.0 | 61.7+/− 10.3 | 63.3 +/− 10.1 | 60.3 +/− 13.2 | ns |
| Height (cm) | 168.3 +/− 9.3 | 171.0 ±10.3 | 167.9 +/− 7.7 | 169.4 +/− 9.1 | 169.9 +/− 8.7 | 167.3 +/− 9.5 | ns |
| Weight (kg) | 84.7 +/− 20.5 | 83.7 +/− 18.2 | 79.9 +/− 17.2 | 169.4 +/− 9.1 | 84.8 +/− 18.1 | 84.6 +/− 22.1 | ns |
| Body-mass index (kg/m2) | 30.2 +/− 8.5 | 29.1 +/− 8.7 | 28.7 +/− 7.8 | 30.1 +/− 8.0 | 29.7 +/− 7.7 | 30.6 +/− 9.0 | ns |
| Baseline SCreat (mg/dL) | 1.03±0.21 | 1.08±0.14 | 1.05±0.26 | 1.02±0.19 | 1.06±0.24 | 1.01±0.19 | ns |
| Admission SCreat (mg/dL) | 1.67 +/− 1.73 | 1.40 +/− 0.958 | 2.20 +/− 1.81 | 2.45 +/− 2.475 | 2.34 +/− 2.35 | 1.24 +/− 0.99 | <0.001 |
| Mortality (%) | 35 (30.2%) | 9 (37.5%) | 6 (40.0%) | 13 (35.1%) | 18 (40.0%) | 17 (23.9%) | ns |
| Obesity (BMI > 30) | 51 (44%) | 10 (41.7%) | 7 (46.7%) | 15 (40.5%) | 19 (42.2%) | 32 (45.1%) | ns |
| Diabetes mellitus | 50 (43.1%) | 9 (37.5%) | 6 (40.0%) | 17 (45.9%) | 16 (35.6%) | 34 (47.6%) | ns |
| Hypertension | 62 (53.4%) | 10 (41.7%) | 8 (53.3%) | 19 (51.4%) | 20 (44.4%) | 42 (59.2%) | ns |
| s/p Transplant | 13 (11.2%) | 1 (4.2%) | 1 (6.7%) | 5 (13.5%) | 6 (13.3%) | 7 (9.9%) | ns |